• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Lancet Reg Health Am . Clinical characteristics of the first and second COVID-19 waves in the Bronx, New York: A retrospective cohort study

tetano

Editor, Senior Moderator
Lancet Reg Health Am


. 2021 Aug 16;100041.
doi: 10.1016/j.lana.2021.100041. Online ahead of print.
Clinical characteristics of the first and second COVID-19 waves in the Bronx, New York: A retrospective cohort study


Wouter S Hoogenboom[SUP] 1 [/SUP], Antoine Pham[SUP] 1 [/SUP], Harnadar Anand[SUP] 1 [/SUP], Roman Fleysher[SUP] 1 [/SUP], Alexandra Buczek[SUP] 1 [/SUP], Selvin Soby[SUP] 2 [/SUP], Parsa Mirhaji[SUP] 2 3 [/SUP], Judy Yee[SUP] 1 [/SUP], Tim Q Duong[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

Background: There is limited clinical patient data comparing the first and second waves of the coronavirus disease 2019 (COVID-19) in the United States and the effects of a COVID-19 resurgence on different age, racial and ethnic groups. We compared the first and second COVID-19 waves in the Bronx, New York, among a racially and ethnically diverse population.
Methods: Patients in this retrospective cohort study were included if they had a laboratory-confirmed SARS-CoV-2 infection by a real-time PCR test of a nasopharyngeal swab specimen detected between March 11, 2020, and January 21, 2021. Main outcome measures were critical care, in-hospital acquired disease and death. Patient demographics, comorbidities, vitals, and laboratory values were also collected.
Findings: A total of 122,983 individuals were tested for SARS-CoV-2 infection, of which 12,659 tested positive. The second wave was characterized by a younger demographic, fewer comorbidities, less extreme laboratory values at presentation, and lower risk of adverse outcomes, including in-hospital mortality (adj. OR = 0·23, 99·5% CI = 0·17 to 0·30), hospitalization (adj. OR = 0·65, 99·5% CI = 0·58 to 0·74), invasive mechanical ventilation (adj. OR = 0·70, 99·5% CI = 0·56 to 0·89), acute kidney injury (adj. OR = 0·62, 99·5% CI = 0·54 to 0·71), and length of stay (adj. OR = 0·71, 99·5% CI = 0·60 to 0·85), with Black and Hispanic patients demonstrating most improvement in clinical outcomes.
Interpretation: The second COVID-19 wave in the Bronx exhibits improved clinical outcomes compared to the first wave across all age, racial, and ethnic groups, with minority groups showing more improvement, which is encouraging news in the battle against health disparities.

Keywords: Bronx; COVID-19; Coronavirus; Ethnicity; Mortality; Race; Resurgence; SARS-CoV-2.
 
Back
Top Bottom